INTRODUCTION
Tanacetum parthenium (L.) Schultz Bip. (Asteraceae) is known in folk medicine as feverfew. This species has been recognized since ancient times as a medicine against a wide range of diseases such as rheumatism, asthma, toothache, and for the alleviation of the "holy fi re", fever and mainly migraine (Knight, 1995; Oliveira et al., 2007; Carvalho et al., 2008) . Since the time of Dioscorides (50 B.C.), feverfew has been used in the prevention of migraine, through the Middle Ages up to the present (Palevitch et al., 1997) .
Phytochemical studies carried out with this species have shown the presence of many constituents, mainly sesquiterpene lactones, and also some fl avonoids. The sesquiterpene lactone parthenolide is the major compound and the chemical marker of T. parthenium (Knight, 1995) .
The commonly used feverfew extracts trigger the release of serotonin (5-HT) from platelets, thus inducing a wide variety of aggregation agents (Pfaffenrath et al., 2002) . The effi cacy of the extract in migraine prophylaxis was also assessed in randomized, placebo-controlled, double-blind and cross-over clinical studies (Gruenwald et al., 2000) .
Pharmacological investigations of feverfew and parthenolide have demonstrated that both present anti-infl ammatory effect through the inhibition of eicosanoids and the transcription factor nuclear factor kappa-B (NF-B) (Gruenwald et al., 2000; GarciaPiñeres et al., 2001; . Further studies revealed that fl avonoids such as santin are also important antiinfl ammatory constituents of the species (Long et al., 2003; Williams et al., 1999) .
Although parthenolide as well as feverfew have been subject to several chemical and pharmacological investigations, a study describing the standardization of its hydroalcoholic extract including fl avonoid analysis and parthenolide quantifi cation is still lacking. Therefore we propose herein a methodology for the quality control of the powder and the hydroalcoholic extract of T. parthenium taking into account the parthenolide and fl avonoid contents.
MATERIAL AND METHODS

Chemicals
Organic solvents for HPLC analyses (Mallinckrodt Baker, Phillipsburg, NJ, USA) were fi ltered through 0.45 m cellulose membranes prior to use. Water was processed in a Millipore, Milli-Q purifi er (Millipore, Bedford, MA, USA). Organic solvents for the other analyses were of analytical grade (Merck or Synth, Brazil). The reagents H 2 SO 4 , HCl, AlCl 3 , AcOH and fructose were obtained from Merck (Brazil). Parthenolide was purchased from SigmaAldrich (Steihem, Germany).
General experimental procedures
The identity of santin was established by 1 H NMR (Bruker DRX 400 spectrometer, 400 MHz, Germany). Flavonoids were quantifi ed in a Hewlett Packard UV-Vis Spectrophotometer, (Kayak, XA, USA), and IR spectra obtained in a Nicolet Protégé 460 spectrophotometer (France).
The HPLC equipment used in the parthenolide quantifi cation consisted of a SLC 10Avp liquid chromatograph (Shimadzu Corp., Japan) with a SPD-M10A diode array detector (DAD), three pumps (LC-10AD), an integration software (Class vp, v. 5.02 ) and an analytical column Nucleosil 100-5 RP-18, 4.6 x 250 mm, 5 m, 100 Å (Macherey & Nagel, Durin, Germany). The HPLC system employed in the analysis of santin was identical to the above, but equipped with two pumps only (LC-6AD), a column oven (CTO-10ASVP) and an analytical column Nucleosil 300-5 RP 18, 4.6 x 250 mm, 5 m, 300 Å (Macherey & Nagel, Durin, Germany).
Plant material
The powder from the aerial parts of T. parthenium was purchased from Galilee Herbal Remedies (Kibbutz Kfar Hanassi, Israel).
Characterization of the T. parthenium powder
Powder fi neness, total ash, acid insoluble ash, swelling index and moisture content: these assays were performed according to the standard methods described in the WHO guidance (Word Health Organization, 1988) .
Extraction, isolation and identifi cation of santin
Extraction of the T. parthenium powder (200 g) using Me 2 CO was proceeded through sonication for 15 min. This procedure was repeated two more times and the resulting solvent was evaporated at reduced pressure. The crude extract (8 g) obtained was submitted to vacuum liquid chromatography (VLC) with silica gel 60H (100-200 mesh ASTM, Merck, Brazil), using nhexane and increasing amounts of EtOAc and MeOH as eluents, yielding seven fractions. Fraction 3 (0.98 g) was chromatographed again by VLC using the same solvent system described above. Fraction 1 (0.74 g) was purifi ed by "fl ash" chromatography using silica gel 60 (230-400 mesh ASTM, Merck, Brazil) as adsorbent. Elution (isocratic) was made with n-hexane:CH 2 Cl 2 :2-propanol 8.0:1.5:0.5 and yielded 28 fractions. Fractions 19-28 (88 mg) were combined and purifi ed by crystallization from n-hexane:MeOH, resulting in 18 mg of pure santin. The structure of the fl avonoid ( Figure 1 ) was established by comparison of its 1 H NMR spectral data with those reported in the literature (Williams et al., 1999) .
Quantifi cation of total fl avonoids by UV spectroscopy
The determination of total fl avonoids was carried out by UV spectroscopy according to the German Pharmacopoeia (Bundesvereinigung, 1986) . The method is based on the use of reagents such as hexamethylenetetramine and AlCl 3 , which ionize phenolic groups and form acid complexes, thus changing the shapes and shifting the absorption peaks of the fl avonoids in the spectrum (Mabry et al., 1970) .
Quantifi cation of parthenolide by HPLC
The parthenolide ( Figure 2 ) content was assessed by an adaptation of the method described by Zhou et al. (1999) with the aid of a calibration curve.
Stock solutions: pure parthenolide (5.0 mg) was placed in a volumetric fl ask and the volume was completed to 5 mL with MeCN. Standard solutions with concentrations of 1, 2, 10, 50, 100, 250, 500, and 750 g/ mL were prepared from the parthenolide stock solution (1 mg/mL) by means of serial dilution with MeCN.
Preparation of sample for analysis: 150 mg of the T. parthenium powder was extracted with 10 mL of MeCN-H 2 O 9:1, sonicated for 30 min and centrifuged for 12 min. For the hydroalcoholic extract, the solvent was evaporated under vacuum and 150 mg of the dried extract was extracted in the same way as above. The supernatant was passed through a 13 mm, 0.45 m nylon membrane (Sartorius, Spain). Aliquots (20 L) of standard solutions of parthenolide or sample were submitted to HPLC in triplicate. A mobile phase consisting of a mixture of MeCN-H 2 O 45:55 was used for the elution, run at a fl ow rate of 1.0 mL/min and UV detection at 210 nm.
Method validation. (a) Calibration curve and linearity: a calibration curve was constructed with standard parthenolide solutions in the concentration range of 1 to 750 g/mL. Injection volumes were 20 L. Each sample was analyzed in triplicate and the average detector responses were used to construct the curve (Brasil, 2002) . (b) Precision and accuracy: three standard solutions in three concentration levels (50, 250 and 750 g/mL) in 10 replicates were employed to observe the standard deviation of the method in the same day (intra-assay precision). For inter-assay precision, a 250 g/mL standard solution was analyzed in 10 replicates during three days. The accuracy was obtained for those three nominal concentrations of parthenolide (50, 250 and 750 g/mL) performed in quintuplicate (Brasil, 2002) . (c) Specifi city: the purity of the parthenolide samples was checked by analyzing the peaks from the chromatogram using DAD (Abourashed and Khan, 2000) . (d) Detection limit (DL) and quantifi cation limit (QL): the standard solution (1 g/mL) was injected three times and the signal height and baseline noises were averaged as follows: DL = 3 x signal height x standard amount/baseline noise, and QL = 10 x signal height x standard amount/baseline noise (Brasil, 2002) .
Preparation
and characterization of the hydroalcoholic extract
The extract was obtained by percolation of the T. parthenium powder in 70% ethanol according to the German Pharmacopoeia specifi cations, as described by Schmidt and List (1989) . Two parts of the extract were obtained from one part of the powder. This process was performed in three steps: 1) pre-swelling, for 2 h with a 1:3 liquid to powder proportion; 2) intermediate maceration (24 h); 3) percolation (4-6 drops/min per 100 g of powder).
Characterization of the hydroalcoholic extract
Loss on drying: performed according to the German Pharmacopoeia (Hartke and Mutschler, 1987) . Density, pH, and alcohol determinations: performed according to the Brazilian Pharmacopoeia (Farmacopéia Brasileira, 1977) . Total fl avonoids: the quantifi cation of total fl avonoids was carried out by UV spectroscopy according to the German Pharmacopoeia (Bundesvereinigung, 1986) . TLC analysis: samples were eluted with C 6 H 6 -Me 2 CO 9:1 in glass plates coated with 0.25 mm of silica gel 60 GF 254 (Merck, Brazil); the reagent used for the detection of spots was a 1% MeOH solution of fructose with 2% H 2 SO 4 1:1; the plates were kept during 2-4 min at 110 o C until the appearance of colored spots (Drozdz and Bloszyk, 1978) ; the retention times of the spots were compared to that of a parthenolide standard. Qualitative analysis of santin: the qualitative analysis of santin in the T. parthenium extract as well as the sample preparation were carried out according to a method described for HPLC analysis of fl avonoids in Passifl ora species (Pereira et al., 2004) . Santin was suspended in 1 mL of MeOH 60% (1 mg/mL), fi ltered through a 0.45 m nylon membrane (Sartorius, Spain) and directly injected into the HPLC system. Injection volumes were 50 L. Parthenolide content: see above.
RESULTS AND DISCUSSION
Validation of the HPLC method
The adaptation of the HPLC method for parthenolide quantifi cation was made in order to improve the specifi city of the parthenolide peak. The method used is fast (run time = 15 min, Fig. 3 ) and simple (isocratic elution). The time of analysis is an important factor in analytical work since it optimizes equipment use and reduces solvent consumption.
A previous study (Zhou et al., 1999) showed that 30 min stirring in MeCN-H 2 O 9:1 is the best system for extracting parthenolide. The calibration curve showed good linearity (R 2 = 0.9994) in the concentration range tested. The regression equation was y = 2.10 -5 x -5.8839. The percentages of relative standard deviation (RSD) were 0.23 to 3.7 %.
Analyses of UV spectra collected at the beginning, in the middle and at the end of the parthenolide peak showed that the method presents specifi city.
The limit of quantifi cation was 0.07 g and the limit of detection was 0.02 g. The method resulted in acceptable intra and inter-assay precision (Tables 1  and 2 ) since the % RSD ranged from 0.34 to 4.1 % for the intra-assay and 0.34 to 2.19 % for the inter-assay tests. The accuracy ranged from 94.09 to 99.99% and is shown in Table 3 . These results are in agreement with literature data (Brasil, 2002; Causon, 1997) and show that the method and sample extraction are reproducible.
Characterization of the T. parthenium powder and hydroalcoholic extract
Several techniques used in this study have already been described in the guidelines of World Health Organization (WHO, 1998) and pharmacopoeias (Farmacopéia Brasileira, 1977) and are essential to ensure authenticity, safety and stability of the plant material and its preparations. Nevertheless, a publication containing a compilation of all these specifi cations for T. parthenium (Table 4) was not yet available.
The low water content in the T. parthenium powder (Table 4) indicates that the plant material is stable. Total ash and acid insoluble ash (Table 4) Table 1 . Intra-assay precision of standard parthenolide for three nominal concentrations (50.0, 250.0 and 750.0 g/mL, n=10). SD = standard deviation; % RSD = relative standard deviation. values are in accordance with literature specifi cations and indicate low content of inorganic and silicon contaminants (WHO, 1998) . The presence of santin (Fig.  1) , parthenolide (Table 4 , Fig. 2 ) and total fl avonoids (Table 4) confi rm the authenticity of the plant material. All results are acceptable since RSD values were lower than 10%.
The effi ciency of the extraction process is infl uenced by the powder fi neness (Table 4) , and the swelling index assay (Table 4) shows the extra-amount of solvent that should be added in the extraction (Schmidt and List, 1989) .
The hydroalcoholic extract was obtained by percolation since it is a dynamic and continuous method and is more effi cient than maceration (Prista and Alves, 1967) . Losses on drying, density, IR and TLC analyses (Table 4) were used to control the extraction procedures.
The UV-visible absorption spectroscopy technique, which was based on the German Pharmacopoeia, allowed the quantifi cation of total fl avonoids in the powder and also in the hydroalcoholic extract (Tables 4 and 5 ).
The result of IR spectroscopic analysis ( Table 5 ) also indicates that the extraction procedure was effi cient for parthenolide and fl avonoids, which are the most important active compounds of feverfew (Gruenwald et al., 2000) .
Several studies suggest that parthenolide, which is thought to be the most active component of T. parthenium, should be used as a chemical marker to characterize T. parthenium. However, parthenolide has also been reported in other Asteraceae species such as the German chamomile [Matricaria recutita (L.) Rausch.] and tansy (Tanacetum vulgare L.). Both drugs are sometimes incorrectly supplied as feverfew (Smith and Burford, 1993) . Therefore, the identifi cation of santin by HPLC as well as quantifi cation of parthenolide as proposed herein are very useful parameters to characterize T. parthenium unequivocally.
The results also showed that the use of hydroalcoholic extracts is more advantageous than the use of the crude powder in order to obtain plantderived products or phytomedicines containing higher amounts of active compounds such as parthenolide and fl avonoids. As demonstrated in the present study, these compounds can be easily analyzed by different qualitative and/or quantitative methods. Although the use of hydroalcoholic extracts is strongly recommended, most of the T. parthenium-derived products sold by several pharmaceutical companies and pharmacies are in form of capsules that simply store the powder of the aerial parts of this plant.
In conclusion, a reliable methodology for the quality control of the powder and the hydroalcoholic extract of T. parthenium is now reported. It takes into account published data, international regulatory demands and governmental guidelines. This methodology may be used as a model by academic researchers as well as pharmaceutical companies for quality control purposes. Once it is properly adapted, it may be applied to other medicinal plants and their extracts.
